当前位置: X-MOL 学术Cancer Genet. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical impact of 5ʹMYC or 3ʹMYC gain/loss detected by FISH in patients with aggressive B-cell lymphomas
Cancer Genetics ( IF 1.9 ) Pub Date : 2022-12-18 , DOI: 10.1016/j.cancergen.2022.12.001
Guilin Tang 1 , Shaoying Li 1 , Gokce A Toruner 1 , Preetesh Jain 2 , Zhenya Tang 1 , Shimin Hu 1 , Jie Xu 1 , Joanne Cheng 1 , Melissa Robinson 1 , Francisco Vega 1 , L Jeffrey Medeiros 1
Affiliation  

FISH analysis using MYC break-apart probes is a widely used technique to assess for MYC rearrangement (MYC-R). Occasionally, FISH results in atypical signal patterns, such as gain or loss of 5ʹMYC or 3ʹMYC. The clinical impact and/or relationship of these atypical signal patterns to MYC-R are unknown. In this study, we assessed 35 patients who had aggressive B-cell lymphomas and exhibited atypical FISH signal patterns: 3ʹMYC deletion (n = 16) or 3ʹMYC deletion plus 5ʹMYC amplification (n = 5), 5ʹMYC gain (n = 10), 5ʹMYC deletion (n = 3), and 3ʹMYC gain (n = 1). For comparison, we also included 9 patients who showed an unbalanced MYC-R. Patients with 5ʹMYC gain showed MYC expression and were often refractory to chemotherapy (n = 7) or had early relapse (n = 2). By contrast, lymphomas with 3ʹMYC deletion were negative or had low expression of MYC (16 of 18), and patients often responded to chemotherapy (16 of 19). The median event-free survival was 24, 6, and 4 months for patients with 3ʹMYC deletion, 5ʹMYC gain and unbalanced MYC-R, respectively (p = 0.0048). We conclude that 5ʹMYC gain is associated with MYC expression and a poorer prognosis and likely represents an unbalanced MYC-R. By contrast, 3ʹMYC deletions are not associated with MYC expression or a poorer prognosis and this finding may be unrelated to MYC-R.



中文翻译:

FISH 在侵袭性 B 细胞淋巴瘤患者中检测到的 5'MYC 或 3'MYC 增益/丢失的临床影响

使用MYC分离探针的FISH 分析是一种广泛使用的技术,用于评估MYC重排 ( MYC -R)。有时,FISH 会导致非典型信号模式,例如 5 ʹ MYC或 3 ʹ MYC 的增益或丢失。这些非典型信号模式与MYC -R的临床影响和/或关系尚不清楚。在这项研究中,我们评估了 35名患有侵袭性 B 细胞淋巴瘤并表现出非典型 FISH 信号模式的患者:3'MYC缺失n = 16  )或 3'MYC缺失加上5'MYC扩增(n = 5), 5 ʹ MYC增益 ( n  = 10), 5 ʹ MYC缺失 ( n  = 3), 和 3 ʹ MYC增益 ( n  = 1)。为了进行比较,我们还纳入了 9 名表现出不平衡的MYC -R 的患者。具有 5 ʹ MYC增益的患者表现出 MYC 表达,并且通常对化疗具有抵抗力 ( n  = 7) 或早期复发 ( n  = 2)。相比之下,具有 3 ʹ MYC 的淋巴瘤缺失为阴性或 MYC 表达低(18 人中有 16 人),患者通常对化疗有反应(19 人中有 16 人)。3 ' MYC缺失、5 ' MYC增加和MYC -R不平衡患者的中位无事件生存期分别为 24、6 和 4 个月( p  = 0.0048)。我们得出结论,5 ʹ MYC增益与 MYC 表达和较差的预后相关,并且可能代表不平衡的MYC -R。相比之下,3'MYC缺失与MYC表达或较差的预后无关,并且这一发现可能与MYC -R 无关。

更新日期:2022-12-23
down
wechat
bug